In the Western cohort, a significant difference was found in OS between the AC and non-AC groups before matching (3-year OS: 64.8% vs 39.5%; P = .004); however, this difference did not reach statistical significance between the 2 groups after matching (3-year OS: 57.3% vs 39.5%; P = .11) (eFigure 3C and D in the Supplement ).
← all excerpts
Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy.
1
0.1100
0.1100